A Rare Case of Polymyxin B Induced Transverse Melanonychia Affecting All 20 Nails
DOI:
https://doi.org/10.2340/actadv.v105.43353Keywords:
melanonychia, drug reaction, antibioticDownloads
References
Singal A, Bisherwal K. Melanonychia: etiology, diagnosis, and treatment. Indian Dermatol Online J 2020; 11: 1.
https://doi.org/10.4103/idoj.IDOJ_167_19 DOI: https://doi.org/10.4103/idoj.IDOJ_167_19
Jefferson J, Rich P. Melanonychia. Dermatol Res Pract 2012; 2012: 952186.
https://doi.org/10.1155/2012/952186 DOI: https://doi.org/10.1155/2012/952186
Mattos KPH, Cintra ML, Gouvêa IR, Ferreira LÁ, Velho PENF, Moriel P. Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process. J Clin Pharm Ther 2017; 42: 573–578.
https://doi.org/10.1111/jcpt.12543 DOI: https://doi.org/10.1111/jcpt.12543
Kura MM, Sonawane PD. Polymyxin B-induced skin and nail hyperpigmentation in an adult. Pigment International 2023; 10: 183–185.
https://doi.org/10.4103/pigmentinternational.pigmentinternational_82_21 DOI: https://doi.org/10.4103/pigmentinternational.pigmentinternational_82_21
Zheng G, Cao L, Che Z, Mao E, Chen E, He J. Polymyxin B-induced skin hyperpigmentation: a rare case report and literature review. BMC Pharmacol Toxicol 2018; 19: 41.
https://doi.org/10.1186/s40360-018-0226-1 DOI: https://doi.org/10.1186/s40360-018-0226-1
Published
How to Cite
License
Copyright (c) 2025 Fatmanur Hacınecipoğlu, Gülten Ütebey, Bahriye Nur Dinçer, Selda Pelin Kartal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.